This study is accepting new patients by invitation only
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Summary
- Eligibility
- for people ages 8-70 (full criteria)
- Location
- at Los Angeles 5368361, California 5332921 and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Alkeus Pharmaceuticals, Inc.
- Links
- Please leave your name if you would like to be contacted to discuss this trial
- ID
- NCT02402660
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 160 study participants
- Last Updated